EU regulator backs authorization for Novavax COVID-19 vaccine, sending stock up 10% premarketMarket Watch • 12/20/21
Novavax Receives Positive European Medicines Agency Recommendation for Conditional Marketing Authorization of its COVID-19 VaccinePRNewsWire • 12/20/21
Rosen, A Leading Law Firm, Encourages Novavax, Inc. Investors with Losses to Secure Counsel Before Important January 11 Deadline in Securities Class Action - NVAXNewsfile Corp • 12/18/21
NVAX Stock Pops as the WHO Grants Novavax's Vaccine Emergency Use. 8 Things to Know.InvestorPlace • 12/17/21
Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 VaccinePRNewsWire • 12/17/21
Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 VaccinePRNewsWire • 12/16/21
Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Novavax, Inc.Newsfile Corp • 12/16/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Novavax (NVAX) Investors to Lead Plaintiff Opportunity in Securities Class Action, Encourages Investors with Losses to Contact Firm's AttorneysNewsfile Corp • 12/15/21